Sometimes a company’s debut or the release of a new product can stir analysts into a frenzy. Other times, careful consideration of long-term trends and performance can drive improved public opinion of a company’s prospects. In such cases, the resulting market conditions offer stocks with analyst recommendations that simply cannot be ignored. That’s because the

Penny stocks are on the riskier end of the public equity spectrum. They are characterized by their low volume, affordable pricing, and the rapid pace at which their values can surge or plummet compared to more traditional stocks. But, for well-informed investors, penny stocks offer a chance to secure substantial gains on the cheap. When

Healthcare stocks certainly haven’t set the world on fire lately. The S&P Health Care Index is up 3% so far in 2024 compared to an 8% gain in the benchmark S&P 500. Yet, many leading healthcare companies just issued better-than-expected financial results for this year’s first quarter. Additionally, these stocks tend to perform well during

Wedbush Securities has a solid track record with many publicly traded companies it covers. Over the past few months, the investment firm hiked its price target on several intriguing companies, many of which may prove great buys after the recent wave of market volatility. Of course, investors shouldn’t treat any analyst rating and price targets

The Dow Jones Industrial Average has been around since 1885. The index contains 30 stocks and has regularly added and removed holdings from the list. An index with 30 stocks has more concentration than indices like the S&P 500 and the Nasdaq 100, which spread their assets across more holdings. However, some Dow stocks to buy are better than others. Investors must

Many of yesterday’s meme stocks to buy, once the darlings of speculative traders, now languish as forgotten relics at the bottom of portfolios, their potential for massive gains long since diminished. This popular sentiment — “It’s only a loss if you sell” — might not hold much comfort anymore. Proving the truism less-than-true, many former

Fortune.com recently reported that artificial intelligence (AI) is helping the pet care industry cope with a chronic veterinary shortage. AI use cases could become far more prevalent for pets than humans in the near term due to fewer impediments such as privacy laws. That’s excellent news for AI pet stocks.  Indeed, animal health innovation is

Sell-side analysts have ratings on specific stocks, and based on them, they recommend to clients whether they should buy, sell or stay away from them. Analyst upgrades and downgrades can significantly influence the stock market, affecting both stocks with analyst upgrades, individual stock prices and broader market sentiment. For example, when an analyst upgrades a

Biotech stocks are full of intriguing innovators who could help pave the way for greater gains over the years ahead. Undoubtedly, it’s virtually impossible to tell exactly which pills, shots and treatments within a firm’s pipeline will eventually evolve into cash flows, let alone blockbuster cash cows. With many clinical trials to pass, even a

Sleeper stocks to buy – based on Nasdaq.com’s glossary – represent securities that offer significant price appreciation potential once its fundamentals have been recognized. That could cover a lot of enterprises so I decided to narrow down the list. Using TipRanks’ Stock Screener, I filtered for ideas that benefit from a series of strong quantitative

Machine learning stocks are on everyone’s radar, if nothing else, for the potentially $80 billion market opportunity up for grabs. Underscoring the enormity of the situation, President Joe Biden has signed an executive order to ensure America, which is expected to have a $21 billion market in 2024, does not get left behind in this

Not every stock crashes with the rest of the market. Some corporations offer high margins of safety and can hold firmly during bad times. Putting some of your capital in these investments can reduce your portfolio’s losses from peak to trough.  However, a small number of stocks can actually perform well when the market crashes. It’s harder to find

While a weakening economy and a subsequent dip in the stock market are unfortunate, they are inevitabilities. Even booming segments like the biotech sector are not immune to the general trend of recessions that Western economies experienced over the last 40 years or so. These downturns, however, provide opportunities for investors to buy stocks at

Finding firms with strong growth potential is essential for healthcare investors looking for large profits. Three exceptional firms have surfaced as strong healthcare stocks. Each exhibits unique approaches and accomplishments in biotechnology, healthcare services, and pharmaceuticals. Solid product leads, especially in the U.S. market, have propelled the first company’s biosimilar industry to an astounding rise.